The effectiveness and safety of oral Chinese patent medicines in treating myocardial infarction complicated with heart failure: a network meta-analysis of 12 interventions - Top-Institutions - MDSpire

The effectiveness and safety of oral Chinese patent medicines in treating myocardial infarction complicated with heart failure: a network meta-analysis of 12 interventions

  • By

  • Yiying Liu

  • Ruikang Liu

  • Kai Yang

  • Jun Li

  • Guancheng Ye

  • Xuanchun Huang

  • Shiyi Tao

  • Tiantian Xue

  • Yulian Yuan

  • May 21, 2026

  • 0 min

Share

Top Institutions in Cardiology

Brief introduction explaining scope and methodology.

  • #1

    Fuwai Hospital, National Center for Cardiovascular Diseases
    Fuwai Hospital, National Center for Cardiovascular Diseases

    Beijing, China

    Key Differentiators

    • Cardiology

  • #2

    Guang’anmen Hospital, China Academy of Chinese Medical Sciences
    Guang’anmen Hospital, China Academy of Chinese Medical Sciences

    Beijing, China

    Key Differentiators

    • Cardiology

  • #3

    Cardiovascular Department, Xiyuan Hospital, China Academy of Chinese Medical Sciences
    Cardiovascular Department, Xiyuan Hospital, China Academy of Chinese Medical Sciences

    Beijing, China

    Key Differentiators

    • Cardiology

  • #4

    Cardiovascular Disease Center, Xiyuan Hospital, National Clinical Research Center for Chinese Medicine Cardiology
    Cardiovascular Disease Center, Xiyuan Hospital, National Clinical Research Center for Chinese Medicine Cardiology

    Beijing, China

    Key Differentiators

    • Cardiology

  • #5

    King’s College London NHS Trust Heart Failure Unit
    King’s College London NHS Trust Heart Failure Unit

    London, UK

    Key Differentiators

    • Cardiology

Original Source(s)

The effectiveness and safety of oral Chinese patent medicines in treating myocardial infarction complicated with heart failure: a network meta-analysis of 12 interventions

  • by Yiying Liu, Ruikang Liu, Kai Yang, Jun Li, Guancheng Ye, Xuanchun Huang, Shiyi Tao, Tiantian Xue, Yulian Yuan

  • May 21, 2026

Related Content

Risk stratification for sudden cardiac death in nonischemic dilated cardiomyopathy: a moving target?

Abnormal active myocardial relaxation by dipyridamole stress test in suspected early-stage heart failure with preserved ejection fraction: a retrospective exploratory analysis

Heterogeneous benefit of early sacubitril/valsartan initiation after PCI in elderly patients with left ventricular dysfunction: myocardial recovery and mid-term cardiovascular outcomes